Safety, tolerability, and antibody response after intradermal vaccination of COVID-19 vaccine; PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)

Authors
Category Primary study
Registry of TrialsTCTR
Year 2023
This article has no abstract
Epistemonikos ID: ae2a82f3793846328f20b8263238e9eb84f1a6d3
First added on: Oct 02, 2023